Soleus Capital Management, L.P. Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$660.6B
Holdings
65
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (65 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 2,825,000 | $397.7B | 60.21% | Put |
| 2 | BCABBIOATLA INC | 1,055,557 | $35.9B | 5.43% | |
| 3 | EPIEURESSA PHARMA INC | 2,375,681 | $28.3B | 4.29% | |
| 4 | OPHTEURIVERIC BIO INC | 1,597,279 | $11.0B | 1.67% | |
| 5 | LNTHLANTHEUS HLDGS INC | 742,085 | $10.0B | 1.52% | |
| 6 | CCCCC4 THERAPEUTICS INC | 268,548 | $8.9B | 1.35% | |
| 7 | IONS 0.125 12/15/24IONIS PHARMACEUTICALS INC | 8,500,000 | $8.7B | 1.31% | |
| 8 | XENEXENON PHARMACEUTICALS INC | 558,117 | $8.6B | 1.30% | |
| 9 | GLTOUSDGALECTO INC | 649,600 | $8.1B | 1.23% | |
| 10 | EX9EXELIXIS INC | 390,847 | $7.8B | 1.19% | |
| 11 | NTRANATERA INC | 74,189 | $7.4B | 1.12% | |
| 12 | VCELVERICEL CORP | 236,589 | $7.3B | 1.11% | |
| 13 | INBXUSDINHIBRX INC | 213,807 | $7.0B | 1.07% | |
| 14 | IRMDIRADIMED CORP | 303,998 | $6.9B | 1.05% | |
| 15 | —TCR2 THERAPEUTICS INC | 199,867 | $6.2B | 0.94% | |
| 16 | DRIOEURDARIOHEALTH CORP | 401,606 | $5.7B | 0.87% | |
| 17 | —MERSANA THERAPEUTICS INC | 206,844 | $5.5B | 0.83% | |
| 18 | SPRYSILVERBACK THERAPEUTICS INC | 107,826 | $5.0B | 0.76% | |
| 19 | —VESPER HEALTHCARE ACQSTN COR | 416,551 | $4.7B | 0.71% | |
| 20 | NVCRNOVOCURE LTD | 24,999 | $4.3B | 0.65% | |
| 21 | —OAKTREE ACQUISITION CORP | 281,565 | $4.1B | 0.62% | |
| 22 | SU6SURMODICS INC | 92,975 | $4.0B | 0.61% | |
| 23 | —MISONIX INC | 301,333 | $3.8B | 0.57% | |
| 24 | AZNASTRAZENECA PLC | 64,284 | $3.2B | 0.49% | |
| 25 | DC4DEXCOM INC | 8,165 | $3.0B | 0.46% | |
| 26 | ALXNALEXION PHARMACEUTICALS INC | 18,938 | $3.0B | 0.45% | |
| 27 | —ITAMAR MED LTD | 140,524 | $2.8B | 0.42% | |
| 28 | ESTAESTABLISHMENT LABS HLDGS INC | 66,921 | $2.5B | 0.38% | |
| 29 | GOSS 5 06/01/27GOSSAMER BIO INC | 2,750,000 | $2.5B | 0.37% | |
| 30 | NEONEOGENOMICS INC | 45,951 | $2.5B | 0.37% | |
| 31 | RFLRAFAEL HLDGS INC | 104,737 | $2.4B | 0.37% | |
| 32 | MRKMERCK & CO. INC | 28,406 | $2.3B | 0.35% | |
| 33 | —TURNING POINT THERAPEUTICS I | 19,013 | $2.3B | 0.35% | |
| 34 | ABBVABBVIE INC | 21,477 | $2.3B | 0.35% | |
| 35 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 185,719 | $2.3B | 0.35% | |
| 36 | CMPSCOMPASS PATHWAYS PLC | 42,743 | $2.0B | 0.31% | |
| 37 | —ONCORUS INC | 56,422 | $1.8B | 0.28% | |
| 38 | PRVBUSDPROVENTION BIO INC | 105,941 | $1.8B | 0.27% | |
| 39 | MRTXEURMIRATI THERAPEUTICS INC | 7,838 | $1.7B | 0.26% | |
| 40 | OSH3EUROAK STR HEALTH INC | 27,612 | $1.7B | 0.26% | |
| 41 | NVROEURNEVRO CORP | 9,589 | $1.7B | 0.25% | |
| 42 | CRSPCRISPR THERAPEUTICS AG | 10,825 | $1.7B | 0.25% | |
| 43 | TREURTRILLIUM THERAPEUTICS INC | 103,819 | $1.5B | 0.23% | |
| 44 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 135,992 | $1.5B | 0.22% | |
| 45 | —KADMON HLDGS INC | 336,442 | $1.4B | 0.21% | |
| 46 | —MIRAGEN THERAPEUTICS INC | 81,185 | $1.3B | 0.20% | |
| 47 | PIRSPIERIS PHARMACEUTICALS INC | 500,000 | $1.3B | 0.19% | |
| 48 | SRRKSCHOLAR ROCK HLDG CORP | 24,484 | $1.2B | 0.18% | |
| 49 | —ZYMEWORKS INC | 22,631 | $1.1B | 0.16% | |
| 50 | CRDFCARDIFF ONCOLOGY INC | 56,909 | $1.0B | 0.16% | |
| 51 | BIIBBIOGEN INC | 3,899 | $955.0M | 0.14% | |
| 52 | HZNPHORIZON THERAPEUTICS PUB L | 12,655 | $926.0M | 0.14% | |
| 53 | RVNCEURREVANCE THERAPEUTICS INC | 31,136 | $882.0M | 0.13% | |
| 54 | —MEDICENNA THERAPEUTICS CORP | 186,799 | $874.0M | 0.13% | |
| 55 | LYRALYRA THERAPEUTICS INC | 74,120 | $845.0M | 0.13% | |
| 56 | KYMRKYMERA THERAPEUTICS INC | 13,116 | $813.0M | 0.12% | |
| 57 | —BIOHAVEN PHARMACTL HLDG CO L | 7,661 | $657.0M | 0.10% | |
| 58 | KRYSKRYSTAL BIOTECH INC | 10,423 | $625.0M | 0.09% | |
| 59 | FATEFATE THERAPEUTICS INC | 6,830 | $621.0M | 0.09% | |
| 60 | AXGNAXOGEN INC | 33,813 | $605.0M | 0.09% | |
| 61 | NVLSEURALPINE IMMUNE SCIENCES INC | 41,064 | $517.0M | 0.08% | |
| 62 | TARAPROTARA THERAPEUTICS INC | 16,093 | $390.0M | 0.06% | |
| 63 | —OAKTREE ACQUISITION CORP | 91,793 | $358.0M | 0.05% | |
| 64 | NVTA1EURINVITAE CORP | 7,024 | $294.0M | 0.04% | |
| 65 | STAASTAAR SURGICAL CO | 3,300 | $261.0M | 0.04% |